Research News and Research

RSS

Health reform implementation: Insurance options, states and exchanges, ACOs

Provisions of the health law that have already been implemented will change next year's insurance offerings -- so employees should pay attention to their options during open season, U.S. News & World Report writes. "You may be able to take advantage of some benefits that kicked in over the past few months under the new health reform law.

30 Oct 2010

NeoPharm enters merger agreement with Insys Therapeutics

NeoPharm, Inc. a biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for cancer and other diseases, today announced it has entered into a merger agreement with Insys Therapeutics, a Phoenix-based drug development company focused on pain and oncology.

30 Oct 2010

Advaxis enters CRADA with NCI for development of live attenuated Listeria vaccines

Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, is pleased to announce it has signed a formal research agreement with the National Cancer Institute at the National Institutes of Health.

30 Oct 2010

Providers brace for health overhaul, seek to improve quality

The (Torrance, Calif.) Daily Breeze: "With health care reform on the way -- bringing with it scores of new Medi-Cal patients -- community clinics that treat mostly low-income and uninsured patients are looking at ways to transform into primary care medical hubs. South Bay Family Health Care, based in Redondo Beach, will get help doing that from Los Angeles County's only public health insurance plan, L.A. Care. The nonprofit health plan has hired a consulting firm to help 11 clinics improve their treatment model over the next two years" (Evans, 10/28).

30 Oct 2010

Bed rest may harm mother and baby in pregnancy complications

Bed rest may not be the best option for preventing preterm labor and may even cause harm to the mother and baby, according to an integrative literature review in a special issue on "Women's Health Across the Lifespan" in Biological Research for Nursing (published by SAGE).

30 Oct 2010

HHS approves hundreds more local Gov'ts, businesses, unions for early retiree health program

The federal Department of Health and Human Services is still accepting applications for the $5 billion program to help cover the cost of retiree health care, the National Journal reports. The agency says 700 more employers have joined the program, raising the total to 3,600.

30 Oct 2010

Agilent opens new life sciences instruments manufacturing facility in Singapore

Agilent Technologies Inc. today announced the opening of its new life sciences instruments manufacturing facility in Singapore. The facility will produce the company's Liquid Chromatography/Mass Spectrometry (LC/MS) instruments for the global market.

30 Oct 2010

Inter Press Service reports on counterfeit medicine challenges in central, Eastern Europe

Central and Eastern Europe is facing 'significant challenges' in combating a multi-billion euro, and often lethal, trade in fake medicines, security and pharmaceutical groups have warned, Inter Press Service reports in an article that examines the scope of the problem in a region now identified as a key smuggling route in an illicit trade which is growing every year.

30 Oct 2010

Medicare pilots deliver mixed savings results

The Fiscal Times explores whether the Medicare pilot programs in the new health law will end up saving money.

30 Oct 2010

Dysfunction of Grhl2 factor may affect epithelial barrier formation, contribute to congenital abnormalities

Scientists of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch and the Experimental and Clinical Research Center (ECRC) of MDC and Charit- in Berlin-Buch have gained new insights into the development of epithelial cells and their molecular repertoire.

30 Oct 2010

Enrollees in high-deductible plans may be forgoing care because of high costs

People enrolled in high-deductible plans may forgo care because of excessive out-of-pocket costs, according to a new report from the UCLA Center for Health Policy Research.

30 Oct 2010

FDA approves NUEDEXTA capsules for pseudobulbar affect

AVANIR Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate) capsules, as the first treatment for pseudobulbar affect.

30 Oct 2010

State Watch: R.I. group experiments with payment reform; Ariz. dispute over abortion; Vt. and Feds to end monitoring of caregivers

The Providence (R.I.) Journal: "The Lifespan hospital group and Blue Cross have reached an agreement intended to gradually overturn the way hospital care is financed, with the goal of promoting health, rather than episodes of treatment. The agreement is the first to meet unique-in-the-nation rules from state Health Insurance Commissioner Christopher F. Koller, who has identified hospital costs as the main reason for increases in health-insurance premiums.

30 Oct 2010

Teflaro receives FDA approval for treatment of bacterial infections

The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI), including methicillin-resistant Staphylococcus aureus (MRSA).

30 Oct 2010

New shuttlte program helps probe spaceflight-induced immune-system impairment

When the space shuttle Discovery lifts off on its final flight Nov. 2, its six astronauts will be joined by 16 rodent passengers on a historic mission of their own. Riding in special self-contained modules that automatically supply them with food and water, the mice will be part of a long-term NASA effort aimed at understanding why spaceflight makes humans more vulnerable to infection by viruses and bacteria.

30 Oct 2010

Recent releases in Global Health

Global Fund Will Make 'Every Possible Effort' To Raise Additional Resources: Although pledges to the Global Fund to Fight AIDS, Tuberculosis and Malaria at its recent replenishment meeting did not meet "the lowest estimate of demand," the Fund "will make every possible effort to raise the additional resources that we expect countries to request in the years ahead" through new donor recruitment and "innovative financing approaches," writes Executive Director Michael Kazatchkine in a Lancet comment

30 Oct 2010

Study suggests curcumin may be an effective therapy for liver fibrosis

Curcumin, a chemical that gives curry its zing, holds promise in preventing or treating liver damage from an advanced form of a condition known as fatty liver disease, new Saint Louis University research suggests.

30 Oct 2010

Drug and device makers face new taxes, fees

A Fox Business report shows the health overhaul is cutting deeper into drug and device makers' profits than many expected. Research & development programs are already being drastically scaled back.

30 Oct 2010

Today's Op-Eds: Competition among insurers; health reform and hospital cuts; Medicare reimbursement crisis

The effect of the regulation will be to drive many small insurers from the market and thus to reduce competition for health insurance. The question is whether a reduction in the number of insurers in a given market area invariably is to the disadvantage of the insured. On this point one's memories of Econ 101 can be quite misleading.

30 Oct 2010

CSL Behring creates Interlaken Leadership Awards to support innovative immunoglobulin research

To demonstrate its continued commitment to innovative immunoglobulin (Ig) research, CSL Behring announced today it has created the Interlaken Leadership Awards. This global awards program will provide monetary grants to advance medical research and knowledge about the potential role of immunoglobulin therapy in the treatment of neurologic disorders.

29 Oct 2010

Research News and Research

Health reform implementation: Insurance options, states and exchanges, ACOs

NeoPharm enters merger agreement with Insys Therapeutics

Advaxis enters CRADA with NCI for development of live attenuated Listeria vaccines

Providers brace for health overhaul, seek to improve quality

Bed rest may harm mother and baby in pregnancy complications

HHS approves hundreds more local Gov'ts, businesses, unions for early retiree health program

Agilent opens new life sciences instruments manufacturing facility in Singapore

Inter Press Service reports on counterfeit medicine challenges in central, Eastern Europe

Medicare pilots deliver mixed savings results

Dysfunction of Grhl2 factor may affect epithelial barrier formation, contribute to congenital abnormalities

Enrollees in high-deductible plans may be forgoing care because of high costs

FDA approves NUEDEXTA capsules for pseudobulbar affect

State Watch: R.I. group experiments with payment reform; Ariz. dispute over abortion; Vt. and Feds to end monitoring of caregivers

Teflaro receives FDA approval for treatment of bacterial infections

New shuttlte program helps probe spaceflight-induced immune-system impairment

Recent releases in Global Health

Study suggests curcumin may be an effective therapy for liver fibrosis

Drug and device makers face new taxes, fees

Today's Op-Eds: Competition among insurers; health reform and hospital cuts; Medicare reimbursement crisis

CSL Behring creates Interlaken Leadership Awards to support innovative immunoglobulin research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News